Replies to post #135454 on Biotech Values

[jq1234]

The ph2b include not just G+ patients, rather significant G+ patients, and likely large majority will be triple negative.

[ghmm]

CLDX R&D Day scheduled for tomorrow at 8:30am

http://earningscast.com/CLDX/20120123
or
http://edge.media-server.com/m/p/639b475g/lan/en

Company Investor Presentation Page
http://ir.celldextherapeutics.com/phoenix.zhtml?c=93243&p=irol-audioarchives